Daljeet Kohli of Roha Asset Managers expresses surprise at the market’s sharp rebound following tariff war announcements. Kohli believes the market anticipates a rollback of tariffs and sees India as a potential beneficiary due to its inherent strengths. While acknowledging potential volatility, Kohli advises investors to remain calm and analyze individual company impacts rather than reacting to macro news.
Pharma stocks rally up to 4%, but will Trump order really have minimal impact?
The Nifty Pharma index gained around 2% on Tuesday, defying the broader market trend, as the Nifty slipped nearly 0.5% amid profit-booking following Monday’s sharp
May 13, 2025